Related references
Note: Only part of the references are listed.Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy
Shoji Tachikawa et al.
CHEMICAL COMMUNICATIONS (2014)
Diaryl-substituted ortho-carboranes as a new class of hypoxia inducible factor-1α inhibitors
Hiroyuki Nakamura et al.
DALTON TRANSACTIONS (2014)
Hsp60 chaperonopathies and chaperonotherapy: targets and agents
Francesco Cappello et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults
Aditya K. Gupta et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Carborane-Based Carbonic Anhydrase Inhibitors
Jiri Brynda et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Identification of Malate Dehydrogenase 2 as a Target Protein of the HIF-1 Inhibitor LW6 using Chemical Probes
Kyeong Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Development of High Boron Content Liposomes and Their Promising Antitumor Effect for Neutron Capture Therapy of Cancers
Hayato Koganei et al.
BIOCONJUGATE CHEMISTRY (2013)
Development of hypoxia-inducible factor (HIF)-1α inhibitors: Effect of ortho-carborane substituents on HIF transcriptional activity under hypoxia
Hiroyuki Nakamura et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Synthesis and Biological Evaluation of Diaryl-Substituted Carboranes as Inhibitors of Hypoxia Inducible Factor (HIF)-1 Transcriptional Activity
Hidemitsu Minegishi et al.
CHEMMEDCHEM (2013)
Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks
Francesco Cappello et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Topoisomerase inhibitors as anticancer agents: a patent update
Daulat B. Khadka et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Boron chemicals in diagnosis and therapeutics
Bhaskar C. Das et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy
Christian Bailly
CHEMICAL REVIEWS (2012)
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
Yan Xia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Boron as a platform for new drug design
Laura Ciani et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Design and synthesis of fluorescence-labeled closo-dodecaborate lipid: its liposome formation and in vivo imaging targeting of tumors for boron neutron capture therapy
Hiroyuki Nakamura et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Discovery of ortho-Carborane-Conjugated Triazines as Selective Topoisomerase I/II Inhibitors
Hiroyuki Nakamura et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2011)
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
Matthias Scholz et al.
CHEMICAL REVIEWS (2011)
Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004-2010)
Hyun Seung Ban et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Boron Cluster-based Development of Potent Nonsecosteroidal Vitamin D Receptor Ligands: Direct Observation of Hydrophobic Interaction between Protein Surface and Carborane
Shinya Fujii et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy
Manabu Ueno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors
Kazuki Shimizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Boron-Containing Protoporphyrin IX Derivatives and Their Modification for Boron Neutron Capture Therapy: Synthesis, Characterization, and Comparative In Vitro Toxicity Evaluation
Mohamed E. El-Zaria et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
Discovery of Carboranes as Inducers of 20S Proteasome Activity
Hyun Seung Ban et al.
CHEMMEDCHEM (2010)
Identification of HSP60 as a Primary Target of o-Carboranylphenoxyacetanilide, an HIF-1α Inhibitor
Hyun Seung Ban et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Selective inhibition of EGFR and VEGFR2 tyrosine kinases controlled by a boronic acid substituent on 4-anilinoquinazolines
Hiroyuki Nakamura et al.
MEDCHEMCOMM (2010)
Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications
Paul C. Trippier et al.
MEDCHEMCOMM (2010)
Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors
Hiroyuki Nakamura et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Proteasome Regulators: Activators and Inhibitors
Li Huang et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Targeting the ubiquitin system in cancer therapy
Daniela Hoeller et al.
NATURE (2009)
Discovery of boron-conjugated 4-anilinoquinazoline as a prolonged inhibitor of EGFR tyrosine kinase
Hyun Seung Ban et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2009)
Impact of accelerator-based boron neutron capture therapy (AB-BNCT) on the treatment of multiple liver tumors and malignant pleural mesothelioma
Minoru Suzuki et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Boron neutron capture therapy for glioblastoma
Tetsuya Yamamoto et al.
CANCER LETTERS (2008)
A combinatorial approach to 2,4,6-trisubstituted triazines with potent antimalarial activity: Combining conventional synthesis and microwave-assistance
Sergio Melato et al.
CHEMMEDCHEM (2008)
Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: Structural modulations of diaryltriazines with potent anti-HIV activity
Yuan-Zhen Xiong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structural Analysis of Spiro β-Lactone Proteasome Inhibitors
Michael Groll et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
The role of photodynamic therapy (PDT) physics
Timothy C. Zhu et al.
MEDICAL PHYSICS (2008)
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
D. Li et al.
ONCOGENE (2008)
Synthesis and characterization of polar functional group substituted mono- and bis-(o-carboranyl)-1,3,5-triazine derivatives
Chai-Ho Lee et al.
TETRAHEDRON LETTERS (2008)
Activation and inhibition of the proteasome by betulinic acid and its derivatives
Li Huang et al.
FEBS LETTERS (2007)
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site
Fernando L. Rock et al.
SCIENCE (2007)
Synthesis of dodecaborate-conjugated cholesterols for efficient boron delivery in neutron capture therapy
Hiroyuki Nakamura et al.
TETRAHEDRON LETTERS (2007)
(Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors
Kyeong Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores
Richard L. Julius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Synthesis of boron cluster lipids:: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy
Jong-Dae Lee et al.
ORGANIC LETTERS (2007)
Recent applications of 2,4,6-trichloro-1,3,5-triazine and its derivatives in organic synthesis
Grzegorz Blotny
TETRAHEDRON (2006)
Transferrin-loaded nido-carborane liposomes: Tumor-targeting boron delivery system for neutron capture therapy
Yusuke Miyajima et al.
BIOCONJUGATE CHEMISTRY (2006)
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), for the potential treatment of onychomycosis
Stephen J. Baker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerzation inhibitors
Hiroyuki Nakamura et al.
CHEMMEDCHEM (2006)
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome
M Groll et al.
STRUCTURE (2006)
Lapatinib: A novel dual tyrosine kinase inhibitor with activity in solid tumors
MH Nelson et al.
ANNALS OF PHARMACOTHERAPY (2006)
From nonpeptide toward noncarbon protease inhibitors:: Metallacarboranes as specific and potent inhibitors of HIV protease
P Cígler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Design and synthesis of a series of melamine-based nitroheterocycles with activity against trypanosomatid parasites
A Baliani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Saururus cernuus lignans -: Potent small molecule inhibitors of hypoxia-inducible factor-1
CF Hossain et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Boron neutron capture therapy of cancer: Current status and future prospects
RF Barth et al.
CLINICAL CANCER RESEARCH (2005)
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
EL Kwak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity
Y Nagumo et al.
BIOCHEMICAL JOURNAL (2005)
Design, synthesis, and biological evaluation of aminoboronic acids as growth-factor receptor inhibitors of EGFR and VEGFR-1 tyrosine kinases
T Asano et al.
CHEMBIOCHEM (2004)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
A new structural class of proteasome inhibitors identified by microbial screening using yeast-based assay
A Asai et al.
BIOCHEMICAL PHARMACOLOGY (2004)
In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: New molecules in anticancer research
R Menicagli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Synthesis and vesicle formation of a nido-carborane cluster lipid for boron neutron capture therapy
H Nakamura et al.
CHEMICAL COMMUNICATIONS (2004)
Effectiveness of BNCT for recurrent head and neck malignancies
I Kato et al.
APPLIED RADIATION AND ISOTOPES (2004)
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer
M Fukuoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
o-Carboranyl derivatives of 1,3,5-s-triazines:: structures, properties and in vitro activities
CH Lee et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2003)
Anthranilic acid amides:: A novel class of antiangiogenic VEGF receptor kinase inhibitors
PW Manley et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor
J Stamos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synthesis and investigation of conformationally restricted analogues of lavendustin A as cytotoxic inhibitors of tubulin polymerization
FR Mu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Proteasome inhibition: a novel approach to cancer therapy
J Adams
TRENDS IN MOLECULAR MEDICINE (2002)
Proteasome inhibitors: from research tools to drug candidates
AF Kisselev et al.
CHEMISTRY & BIOLOGY (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Potent estrogen agonists based on carborane as a hydrophobic skeletal structure - A new medicinal application of boron clusters
Y Endo et al.
CHEMISTRY & BIOLOGY (2001)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
